Výsledky vyhledávání - Barbara Pro
- Zobrazuji výsledky 1 - 20 z 62
- Přejít na další stránku
-
1
-
2
Brentuximab Vedotin in CD30+ Lymphomas Autor Guilherme Fleury Perini, Barbara Pro
Vydáno 2013Revisão -
3
How I treat posttransplant lymphoproliferative disorder Autor Jennifer E. Amengual, Barbara Pro
Vydáno 2023Artigo -
4
Hepatosplenic T-cell lymphoma: a rare but challenging entity Autor Barbara Pro, Pamela B. Allen, Amir Behdad
Vydáno 2020Revisão -
5
-
6
Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial Autor Francine M. Foss, Sarah McCue Horwitz, Barbara Pro, H. Miles Prince, Lubomir Sokol, Barbara Balser, Julie Wolfson, Bertrand Coiffier
Vydáno 2016Artigo -
7
-
8
-
9
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma Autor Yasuhiro Oki, Barbara Pro, Luis Fayad, Jorge Romaguera, Felipe Samaniego, Fredrick Hagemeister, Sattva S. Neelapu, Peter McLaughlin, André Goy, Anas Younes
Vydáno 2007Artigo -
10
Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma Autor Elias Jabbour, Chitra Hosing, Gregory D. Ayers, Rodolfo Núñez, Paolo Anderlini, Barbara Pro, Issa F. Khouri, Anas Younes, Fredrick B. Hagemeister, Larry W. Kwak, Luis Fayad
Vydáno 2007Artigo -
11
Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma Autor Jia Ruan, Jasmine M. Zain, Brett Alan Palmer, Borko Jovanovic, Xinlei Mi, Alok Swaroop, Jane N. Winter, Leo I. Gordon, Reem Karmali, Jonathan Moreira, Adam M. Petrich, Barbara Pro
Vydáno 2023Artigo -
12
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma Autor Bita Esmaeli, Peter McLaughlin, Barbara Pro, Felipe Samaniego, Isis Gayed, Fredrick B. Hagemeister, Jorge Romaguera, Fernando Cabanillas, Sattva S. Neelapu, R. Banay, Luis Fayad, M. Wayne Saville, Larry W. Kwak
Vydáno 2009Artigo -
13
Progression of undiagnosed cutaneous lymphoma after anti–tumor necrosis factor-alpha therapy Autor Maria Estela Martínez‐Escala, Alba Posligua, Heather Wickless, Audrey Rutherford, Kimberly A. Sable, Belén Rubio-González, Xiaolong Zhou, Jason Kaplan, Barbara Pro, Jaehyuk Choi, Christiane Querfeld, Steven T. Rosen, Joan Guitart
Vydáno 2018Artigo -
14
Single agents vs combination chemotherapy in relapsed and refractory peripheral T‐cell lymphoma: Results from the comprehensive oncology measures for peripheral T‐cell lymphoma tre... Autor Robert Stuver, Niloufer Khan, Marc Schwartz, Mark Acosta, Massimo Federico, Christian Gisselbrecht, Steven M. Horwitz, Frederik Lansigan, Lauren Pinter‐Brown, Barbara Pro, Andrei R. Shustov, Francine M. Foss, Salvia Jain
Vydáno 2019Artigo -
15
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma Autor Barbara Pro, Brian Leber, Mitchell R. Smith, Luis Fayad, Jorge Romaguera, Fredrick B. Hagemeister, Maria Alma Rodriguez, Peter McLaughlin, Felipe Samaniego, James A. Zwiebel, Adriana López, Larry W. Kwak, Anas Younes
Vydáno 2008Artigo -
16
Brentuximab Vedotin in the Front-Line Treatment of Patients With CD30<sup>+</sup> Peripheral T-Cell Lymphomas: Results of a Phase I Study Autor Michelle A. Fanale, Steven M. Horwitz, Andres Forero‐Torres, Nancy L. Bartlett, Ranjana H. Advani, Barbara Pro, Robert W. Chen, Andrew Davies, Tim Illidge, Dirk Huebner, Dana A. Kennedy, Andrei R. Shustov
Vydáno 2014Artigo -
17
Phase II Study of Yttrium-90–Ibritumomab Tiuxetan in Patients With Relapsed or Refractory Mantle Cell Lymphoma Autor Michael Wang, Yasuhiro Oki, Barbara Pro, Jorge Romaguera, Maria Alma Rodriguez, Felipe Samaniego, Peter McLaughlin, Frederick Hagemeister, Sattva S. Neelapu, Amanda Copeland, Barry I. Samuels, Evelyne M. Loyer, Yuan Ji, Anas Younes
Vydáno 2009Artigo -
18
Comparison of Survival in Patients with T Cell Lymphoma after Autologous and Allogeneic Stem Cell Transplantation as a Frontline Strategy or in Relapsed Disease Autor Amer Beitinjaneh, Rima M. Saliba, L. Jeffrey Medeiros, Francesco Turturro, Gabriela Rondón, Martin Körbling, Luis Fayad, Michelle A. Fanale, Amin M. Alousi, Paolo Anderlini, Betül Oran, Uday Popat, Barbara Pro, Issa F. Khouri
Vydáno 2015Artigo -
19
Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients Autor Maria L. Espinosa, Morgan Nguyen, Amaia Saenz Aguirre, Maria Estela Martínez‐Escala, Jane Kim, Christina J. Walker, David Pontes, Jonathan I. Silverberg, Jaehyuk Choi, Barbara Pro, Laura B. Pincus, Joan Guitart, Xiaolong Zhou
Vydáno 2020Artigo -
20
Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium Autor Sonali M. Smith, Koen van Besien, Theodore Karrison, Janet Dancey, Peter McLaughlin, Anas Younes, Scott E. Smith, Patrick J. Stiff, Eric P. Lester, Sanjiv Modi, L. Austin Doyle, Everett E. Vokes, Barbara Pro
Vydáno 2010Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Lymphoma
Oncology
Chemotherapy
Surgery
Immunology
Gastroenterology
Immune system
Biology
T cell
Astrobiology
Refractory (planetary science)
Rituximab
Peripheral T-cell lymphoma
Biochemistry
Cyclophosphamide
Phases of clinical research
Physics
Transplantation
Brentuximab vedotin
Vincristine
Adverse effect
Gene
Mantle cell lymphoma
Neutropenia
Pathology
CD30
Clinical trial
Disease